ClinicalTrials.gg
TerminatedNCT02461654EPCSIIIUpdated Jan 13, 2022

EuroPainClinics® Study III (Prospective Observational Study)

An observational study in Disc Herniations, sponsored by EPC Education s.r.o.. Terminated at 1 site in Czechia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-01-13.

Sponsored by EPC Education s.r.o. · Observational

Why this study was terminated
The clinical trial was suspended for the reason that preliminary results in 20 patients didn't show a significant curative effect of observed treatment.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years and older
Sex
All
01

Study summary

In this prospective observational trial the effect of the Disc FX microinvasive therapy should be examined in (approximately 150) adult patients with low back pain.

Read the detailed description

Patients will be selected from 4 participating clinics from Czech and Slovak republic. Trial will compare evolution of patient's health state, changes of low back pain and other neurological conditions during time period (6 and 12 month) after miniivasive interventional pain release procedure - disc FX.

Back pain due to Lumbar Disc Disease in our population is a very common problem. The treatment options range from physiotherapy to fusion surgery. When all conservative treatment is failed than in some cases with suitable conditions of intervertebral disc is possible to avoid classical disc surgery with minimally invasive surgery techniques. A number of minimally invasive procedures have also been developed in the recent past for its management. One of them is Disc FX procedure. Disc FX is an innovative system allowing for a safe and effective approach to a damaged disc without injury to the surrounding structures. This method provides an option for those people who have not benefited from conservative treatment, and are not yet ready for major surgery. It is a minimal-access procedure performed on an out-patient basis. Its big advantage is the fact that the patient may go home the same day. The procedure consists of three phases: during the first phase, the disc is punctured with a special needle that functions as a working channel. This needle is used to remove part of the degenerate inner tissue. Then, using a radio-frequency probe, the disc is sealed to minimize the risk of repeated herniation. In the final step, the pathological nerves in the back part of the disc are destroyed with the use of radio-frequency.

Trial will compare evolution of patient's health state, changes of low back pain and other neurological conditions during time period (6 and 12 month) after miniivasive interventional pain release procedure - disc FX.

02

Conditions studied

  • Disc Herniations
03

In context

Intervertebral Disc Displacement

491 studies on the registry are indexed under Intervertebral Disc Displacement; 104 are open to participants now.

This study's enrollment of 150 is above the median of 100 across 123 observational studies indexed under Intervertebral Disc Displacement.

Browse Intervertebral Disc Displacement studies →

Lead sponsor

EPC Education s.r.o. is the lead sponsor of 8 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Trial will compare evolution of patient's health state, changes of low back pain and other neurological conditions during time period (6 and 12 month) after miniivasive interventional algesiologic procedure - disc FX.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who undergo Disc FX therapy

Exclusion criteria

Exclusion Criteria:

  • No
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (actual)
Patient registry
No

Interventions

  • OtherDisc FX

    Disc FX is an innovative system allowing for a safe and effective approach to a damaged disc without injury to the surrounding structures. The procedure consists of three phases: during the first phase, the disc is punctured with a special needle that functions as a working channel. This needle is used to remove part of the degenerate inner tissue. Then, using a radio-frequency probe, the disc is sealed to minimize the risk of repeated herniation. In the final step, the pathological nerves in the back part of the disc are destroyed with the use of radio-frequency.

06

What researchers measure

Primary outcomes

  1. Pain as assessed by the Visual analogue scale

    All acquired information will be noted in to the special anonymous protocol

    Time frame: 3 years

Secondary outcomes

  1. Pain localization as assessed by note of radiating dermatome as neurologic examination

    All acquired information will be noted in to the special anonymous protocol

    Time frame: 3 years

  2. Pain progress as assessed by global pain scale

    All acquired information will be noted in to the special anonymous protocol

    Time frame: 3 years

  3. Changes in analgesics drugs consumption as assessed by equianalgesic dose ratios for opioids

    All acquired information will be noted in to the special anonymous protocol

    Time frame: 3 years

07

Study locations

1 site
  • Algesiology ambulance
    Prague, Czechia
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Dec 2018 to primary completion in May 2021, 29 months.

How these figures are worked out, and which studies are left out of them.

Registered
May 26, 2015
First posted
Jun 3, 2015
StartActual
Dec 31, 2018
Primary completionActual
May 31, 2021
CompletionActual
Dec 31, 2021
Last update
Jan 13, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02461654
Lead sponsor
EPC Education s.r.o.
Responsible party
Sponsor
First posted
Jun 3, 2015
Start date
Dec 31, 2018
Primary completion
May 31, 2021
Completion
Dec 31, 2021
Last update
Jan 13, 2022

Study contacts

Juraj Mláka, MD PhD
study chair · R-Clinic
Ladislav Kočan, MD PhD
study director · K-medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion